WO2006107134A1 - Method for preparing valienamine - Google Patents
Method for preparing valienamine Download PDFInfo
- Publication number
- WO2006107134A1 WO2006107134A1 PCT/KR2005/004093 KR2005004093W WO2006107134A1 WO 2006107134 A1 WO2006107134 A1 WO 2006107134A1 KR 2005004093 W KR2005004093 W KR 2005004093W WO 2006107134 A1 WO2006107134 A1 WO 2006107134A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- valienamine
- acarbose
- base
- hydroxide
- amberlite
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Definitions
- the invention relates to a method for preparing valienamine represented by the following formula (1). More particularly, the invention relates to a method for preparing valienamine from acarbose or acarbose derivatives by using a base.
- Valienamine is a core precursor used for preparing voglibose which is an effective hypoglycemics for treating diabetes, suppressing a sudden rise in blood sugar level after a meal [Carbohydrate Research, 140, 185 (1985); J. Med. Chem., 29, 1038 (1988); U.S. patent No. 4,701,559 (1987)].
- valienamine The conventional synthetic methods of valienamine are divided into two types.
- the first type is a total synthesis of valienamine from carbohydrates, and the second type is a preparation of valienamine from validamycin or acarbose having a valienamine moiety therein. Disclosure of Invention Technical Problem
- valienamine In the total synthesis of valienamine from carbohydrates, valienamine is economically prepared from carbohydrate sources such as D-glucose [Chem. Pharm. Bull., 36,4236 (1988); J. Org. Chem., 57, 3651 (1992)] and D-Xylose [J. Antibiot., 53, 430 (2000)]. However, the total synthesis is inadequate for mass production of valienamine since the synthesis reaction is too complicated due to its at least ten reaction steps.
- valienamine derivatives were prepared in a yield of about 36% to about 50% by reacting a validoxyamine derivative having benzyl protection group, which is prepared from validamycin, with NBS (N-bromosuccinimide) under a solvent such as DMF (dimethylformamide) or DMSO (dimethylsulfoxide) [Chemistry Letters, 725 (1989); J. Chem. Soc, Perkin Trans I, 3287 (1991)].
- the method also has some defects because a harmful reagent such as DMF, DMSO, and NBS is used as a solvent or an oxidizing agent, and various by-products are produced.
- WO 2004/000782 describes a new method for preparing valienamine from acarbose or validamycin under a strong acid solvent of TFA (trifluoroacetic acid).
- TFA trifluoroacetic acid
- valienamine can be easily obtained from acarbose or acarbose derivatives using a base, so the present invention is an economic method, which is suitable for the mass production of valienamine.
- the object of the present invention is to provide a method for preparing valienamine from acarbose or acarbose derivatives using a base to solve the problems resulting from the conventional methods for preparing valienamine.
- the present invention provides a method for preparing valienamine represented by the formula (1) from acarbose represented by the formula (2) or acarbose derivatives using a base.
- Acarbose derivatives are compounds having one or more saccharides bonded to a valienamine backbone, and they are generally derivatives having monosaccharide or disaccharide represented by the following formulas.
- acarbose derivative (disacchaiide) (monosaccharide)
- a low-priced reagent a base
- the present invention is an economical method that is suitable for mass production. Best Mode for Carrying Out the Invention
- inorganic bases and organic bases may be used as a base, for example, it is not particularly limited, hydroxides, carbonates, bicarbonates, phosphates, organic amines, and the like.
- Suitable bases include hydroxides, e.g. alkali metal hydroxides such as sodium hydroxide (NaOH), potassium hydroxide (KOH), alkaline earth metal hydroxides such as calcium hydroxide (Ca(OH) ), barium hydroxide (Ba(OH) ), tetraammonium hydroxide such as tetramethylammonium hydroxide (NMe OH), tetraethylammonium
- alkali metal hydroxides such as sodium hydroxide (NaOH), potassium hydroxide (KOH)
- alkaline earth metal hydroxides such as calcium hydroxide (Ca(OH) ), barium hydroxide (Ba(OH) ), tetraammonium hydroxide such as tetramethylammonium hydroxide (NMe OH), tetraethylammonium
- NEt OH hydroxide
- carbonates e.g. metal carbonate (MCO ) (wherein M is alkali metals or alkaline earth metals) such as sodium carbonate (Na CO ), potassium carbonate (K CO ); bicarbonates, e.g. metal bicarbonate (MHCO ) such as sodium bicarbonate (NaHCO ), potassium bicarbonate (KHCO ) ; phosphates such as sodium phosphate tribasic (Na PO ), potassium phosphate tribasic (K PO ), sodium phosphate dibasic (Na HPO ); and organic amines, e.g.
- MCO metal carbonate
- MHCO metal bicarbonate
- phosphates such as sodium phosphate tribasic (Na PO ), potassium phosphate tribasic (K PO ), sodium phosphate dibasic (Na HPO ); and organic amines, e.g.
- NR R R (wherein R ,R , andR may be the same or different, and are independently alkyl group with a carbon number of 1 to 4) such as diisopropylethylamine, tripropylamine, triethylamine.
- a base strength may be considered to choose a suitable base among the various bases.
- the base strength is the most important factor to determine a reaction velocity and a reaction condition. If the base strength is higher, the reaction velocity is relatively faster.
- the base strength is indicated as a dissociation constant (pKa).
- pKa dissociation constant
- the pKa of hydroxyl group (OH ) is 15.7
- the pKa of carboxyl group (CO ) is 10.3
- the pKa of organic amine is 10
- the pKa of triphosphate group (PO ) is 12.7
- the pKa of bicarbonate group (HCO ) is 6.4.
- An amount of the base is not particularly limited, but it is preferable to use an excess amount than that of acarbose or its derivatives. Preferably, an amount of the base is preferable to 5 or more equivalents of acarbose or its derivatives.
- a reaction solvent e.g. water, or a mixture of water and a water-miscible organic solvent may be used for a smooth reaction of the reactants.
- a preferred water- miscible organic solvent is an alcohol such as methanol, ethanol, and ethylene glycol.
- An amount of the reaction solvent is not particularly limited, but it is preferable to use 5 times or more by weight of acarbose or its derivatives, and more preferable to use 5 times to 30 times by weight of acarbose or its derivatives. It is preferred that the reflux of the reaction mixture is carried out during the reaction.
- the preferred reaction temperature is 6O 0 C or higher, and the preferred reaction time is 12 hours or longer. The more preferred reaction temperature is 8O 0 C to 12O 0 C, and the more preferred reaction time is 24 hours to 72 hours.
- the resulting valienamine from the reaction mixture may be easily purified by a conventional purification method in the art.
- an ion exchange resin may be used considering the physical properties of valienamine such as water-solubility.
- the resulting valienamine may be further purified using a purification method such as crystallization.
- a saccharide(s) combined with a backbone of acarbose are removed using a base, so acarbose derivatives, which are different only from the number of saccharides combined thereto as compared with acarbose, are subject to follow the same reaction path as acarbose. Therefore, the reaction conditions and the purification process of acarbose derivatives are substantially identical with those of acarbose as shown in the following reaction formula 2.
- the base may be the same defined as above.
- Acarbose (1Og) and sodium hydroxide (9.3g) were added to water (20OmL) and then refluxed during 48 hours.
- the reaction mixture was cooled to room temperature, neutralized with IN hydrochloric acid solution, and then concentrated.
- the concentrated reaction mixture was purified with cation exchange resin (Amberlite IR- 120H) and weak acid cation exchange resin (Amberlite CG-50). As a result, pure valienamine (l.lg) was obtained.
- Acarbose (1Og) and potassium hydroxide (10.5g) were added to water (18OmL) and then refluxed during 48 hours.
- the reaction mixture was cooled to room temperature, neutralized with IN hydrochloric acid solution, and then concentrated.
- the concentrated reaction mixture was purified with cation exchange resin (Amberlite IR- 120H) and weak acid cation exchange resin (Amberlite CG-50). As a result, pure valienamine (1.Og) was obtained.
- Acarbose (1.Og) and calcium hydroxide (1.6g) were added to water (2OmL) and then refluxed during 60 hours.
- the reaction mixture was cooled to room temperature, and then concentrated.
- the concentrated reaction mixture was purified with cation exc hange resin (Amberlite IR- 120H) and weak acid cation exchange resin (Amberlite CG- 50). As a result, pure valienamine (0.12g) was obtained.
- Acarbose (1.Og) and sodium carbonate (2.Og) were added to water (2OmL) and then refluxed during 72 hours.
- the reaction mixture was cooled to room temperature, and then concentrated.
- the concentrated reaction mixture was purified with cation exchange resin (Amberlite IR- 120H) and weak acid cation exchange resin (Amberlite CG-50). As a result, pure valienamine (0.08g) was obtained.
- Acarbose (1.Og) and sodium bicarbonate (1.8g) were added to water (2OmL) and then refluxed during 72 hours.
- the reaction mixture was cooled to room temperature, and then concentrated.
- the concentrated reaction mixture was purified with cation exchange resin (Amberlite IR- 120H) and weak acid cation exchange resin (Amberlite CG-50). As a result, pure valienamine (0.09g) was obtained.
- Acarbose derivative (disaccharide, 2.Og) and potassium hydroxide (2.Og) were added to water (4OmL) and then refluxed during 48 hours.
- the reaction mixture was cooled to room temperature, neutralized with IN hydrochloric acid solution, and then concentrated.
- the concentrated reaction mixture was purified with cation exchange resin (Amberlite IR- 120H) and weak acid cation exchange resin (Amberlite CG-50). As a result, pure valienamine (0.2g) was obtained.
- Acarbose derivative (disaccharide, 2.Og) and sodium hydroxide (1.6g) were added to water (4OmL) and then refluxed during 40 hours. The reaction mixture was cooled to room temperature, and then concentrated. The concentrated reaction mixture was purified with cation exchange resin (Amberlite IR- 120H) and weak acid cation exchange resin (Amberlite CG-50). As a result, pure valienamine (0.18g) was obtained.
- Example 9 Preparation of Valienamine from Acarbose (9)
- Acarbose (2g) and potassium phosphate tribasic (9.8g) were added to water (2OmL) and then refluxed during 45 hours.
- the reaction mixture was cooled to room temperature, neutralized with IN hydrochloric acid solution, and then concentrated.
- the concentrated reaction mixture was purified with cation exchange resin (Amberlite IR- 120H) and weak acid cation exchange resin (Amberlite CG-50). As a result, pure valienamine (0.17g) was obtained.
- Acarbose (2g) and sodium phosphate tribasic (7.5g) were added to water (2OmL) and then refluxed during 48 hours.
- the reaction mixture was cooled to room temperature, neutralized with IN hydrochloric acid solution, and then concentrated.
- the concentrated reaction mixture was purified with cation exchange resin (Amberlite IR- 120H) and weak acid cation exchange resin (Amberlite CG-50). As a result, pure valienamine (0.19g) was obtained.
- valienamine (0.16g) was obtained.
- Industrial Applicability [62] The conventional synthetic methods of valienamine are inadequate for mass production of the product since they are too complicated due to so many reaction steps and they produce many by-products.
- the present invention provides a method of preparing valienamine suitable for mass production by simplifying the reaction steps and diminishing byproducts. Moreover, the present invention uses a base for the reaction of acarbose or acarbose derivatives so it is a less harmful method in comparison with the conventional methods that uses harmful organic solvents.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05821418A EP1863754A1 (en) | 2005-03-16 | 2005-12-02 | Method for preparing valienamine |
| JP2007542924A JP4639236B2 (en) | 2005-03-16 | 2005-12-02 | Method for producing varienamin |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2005-0021852 | 2005-03-16 | ||
| KR20050021852 | 2005-03-16 | ||
| KR10-2005-0036755 | 2005-05-02 | ||
| KR1020050036755A KR100593849B1 (en) | 2005-03-16 | 2005-05-02 | How to prepare ballienamine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2006107134A1 true WO2006107134A1 (en) | 2006-10-12 |
Family
ID=37073662
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/KR2005/004093 Ceased WO2006107134A1 (en) | 2005-03-16 | 2005-12-02 | Method for preparing valienamine |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP1863754A1 (en) |
| WO (1) | WO2006107134A1 (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4486602A (en) * | 1980-10-06 | 1984-12-04 | Takeda Chemical Industries, Ltd. | Valienamine derivatives, their production and use |
| WO2004000782A1 (en) * | 2002-06-25 | 2003-12-31 | B T Gin., Inc. | Preparation method of valienamine from acarbose and/or acarbose derivatives using trifluoroacetic acid |
| WO2004108657A1 (en) * | 2003-06-11 | 2004-12-16 | B T Gin., Inc. | Preparation method of valienamine using solid catalysts |
-
2005
- 2005-12-02 EP EP05821418A patent/EP1863754A1/en not_active Withdrawn
- 2005-12-02 WO PCT/KR2005/004093 patent/WO2006107134A1/en not_active Ceased
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4486602A (en) * | 1980-10-06 | 1984-12-04 | Takeda Chemical Industries, Ltd. | Valienamine derivatives, their production and use |
| WO2004000782A1 (en) * | 2002-06-25 | 2003-12-31 | B T Gin., Inc. | Preparation method of valienamine from acarbose and/or acarbose derivatives using trifluoroacetic acid |
| WO2004108657A1 (en) * | 2003-06-11 | 2004-12-16 | B T Gin., Inc. | Preparation method of valienamine using solid catalysts |
Non-Patent Citations (1)
| Title |
|---|
| TAIFO MAHMUD ET AL.: "Biosynthetic Studies on the alpha-Glucosidase Inhibitor Acarbose in Actinoplanes sp.: 2-epi-5-epi-Valiolone Is the Direct Precursor of the Valienamine Moiety", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 121, no. 30, 1999, pages 6973 - 6983, XP008047195 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1863754A1 (en) | 2007-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8338645B2 (en) | Method for producing a β-alkoxypropionamide | |
| CA2801101C (en) | Process for preparing a biphenyl-2-ylcarbamic acid | |
| JPS6241702B2 (en) | ||
| EP3424896B1 (en) | Method for producing liquid composition containing monoetherate, liquid composition, and method for producing polymerizable compound | |
| BRPI0706719B1 (en) | process to produce high purity monopentaerythritol and monopentaerythritol produced by | |
| US20170342100A1 (en) | Processes for the preparation of ertugliflozin | |
| US10870671B2 (en) | Method of preparation of alpha galactosyl ceramides compounds | |
| US20160115191A1 (en) | Novel Polymorph of Regadenoson | |
| JP2825132B2 (en) | New method for producing compounds | |
| US10221148B2 (en) | Compositions of mono-alkyl ethers of monoanhydro-hexitols, production methods thereof and use of same | |
| JP4639236B2 (en) | Method for producing varienamin | |
| WO2006107134A1 (en) | Method for preparing valienamine | |
| EP2714691B1 (en) | Process for the preparation of 2-amino-9-((2-phenyl-1,3-dioxan-5-yloxy)methyl)-1h-purin-6(9h)-one compound useful in the preparation of valganciclovir | |
| JP5252468B2 (en) | Method for synthesizing mycoplasma pneumoniae specific antigen glycolipid | |
| CN110759957B (en) | Isoguanosine intermediates, process for producing the same, isoguanosine compounds, process for producing the same, and downstream products thereof | |
| DK170051B1 (en) | 14-Chlordaunomycin and acid addition salts thereof, process for the preparation of (2 "R) -4'-O-tetrahydropyranyladriamycin and (2" R) -14-chloro-4'-O-tetrahydropyranyldunomycin | |
| KR100662110B1 (en) | Method for preparing tetrazole derivatives | |
| US20140235840A1 (en) | New synthesis of fucose | |
| WO2013150020A1 (en) | Process for making bendamustine | |
| CN111793071B (en) | Synthetic process of augustine | |
| EP1193263B1 (en) | Process for producing pyrone compounds | |
| EP2834215B1 (en) | Process for making bendamustine | |
| JP2008247889A (en) | Process for producing ε-caprolactone compound | |
| US20140235848A1 (en) | Method for making a precursor of l-fucose from d-glucose | |
| JPH07138278A (en) | Cellobiose derivative and cello-oligomer derivative and methods for producing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| WWE | Wipo information: entry into national phase |
Ref document number: 2005821418 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 1342/KOLNP/2007 Country of ref document: IN |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 200580036363.X Country of ref document: CN |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2007542924 Country of ref document: JP |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| NENP | Non-entry into the national phase |
Ref country code: RU |
|
| WWP | Wipo information: published in national office |
Ref document number: 2005821418 Country of ref document: EP |






